Literature DB >> 18240651

The relationship between alcoholism and DBI gene polymorphism in Japanese--genotyping of the +529A/T in DBI gene polymorphism based on PCR.

Chikako Waga1, Kazutaka Ikeda, Kazuhiko Iwahashi.   

Abstract

As a help of elucidate of the pathogenesis of alcohol dependence, we investigated the relationship between the genetic variants of the diazepam biding inhibitor (DBI) gene polymorphism and alcoholism. We analyzed the DBI genotypes using a polymerase chain reaction with confronting two-pair novel primers (PCR-CTPP) method in 180 healthy controls and 43 alcoholic. There was a significant difference in the +529A/T (rs8192503) polymorphism allele frequency of the DBI gene (P = 0.0421) between the current alcoholics and healthy controls. The present data using the novel PCR method suggested that mutation allele of the DBI gene polymorphism was one of the risk factors for alcoholism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18240651

Source DB:  PubMed          Journal:  Nihon Arukoru Yakubutsu Igakkai Zasshi        ISSN: 1341-8963


  3 in total

Review 1.  Common and specific liability to addiction: approaches to association studies of opioid addiction.

Authors:  David A Nielsen; Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2012-04-27       Impact factor: 4.492

2.  Co-administration of ethanol and nicotine: the enduring alterations in the rewarding properties of nicotine and glutamate activity within the mesocorticolimbic system of female alcohol-preferring (P) rats.

Authors:  Gerald A Deehan; Sheketha R Hauser; R Aaron Waeiss; Christopher P Knight; Jamie E Toalston; William A Truitt; William J McBride; Zachary A Rodd
Journal:  Psychopharmacology (Berl)       Date:  2015-08-26       Impact factor: 4.530

3.  Heroin addiction in African Americans: a hypothesis-driven association study.

Authors:  O Levran; D Londono; K O'Hara; M Randesi; J Rotrosen; P Casadonte; S Linzy; J Ott; M Adelson; M J Kreek
Journal:  Genes Brain Behav       Date:  2009-06-20       Impact factor: 3.449

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.